123 related articles for article (PubMed ID: 6137979)
21. Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium.
Gibson FM; Mirakhur RK; Clarke RS; Lavery GG
Br J Anaesth; 1985 Nov; 57(11):1060-2. PubMed ID: 2864944
[TBL] [Abstract][Full Text] [Related]
22. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
[TBL] [Abstract][Full Text] [Related]
23. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of vecuronium in adolescents and children.
Goudsouzian NG; Martyn JJ; Liu LM; Gionfriddo M
Anesth Analg; 1983 Dec; 62(12):1083-8. PubMed ID: 6139963
[TBL] [Abstract][Full Text] [Related]
25. Interactions of diisopropyl phenol (ICI 35868) with suxamethonium, vecuronium and pancuronium in vitro.
Fragen RJ; Booij LH; van der Pol F; Robertson EN; Crul JF
Br J Anaesth; 1983 May; 55(5):433-6. PubMed ID: 6133527
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular effects of doxacurium, pancuronium and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery.
Emmott RS; Bracey BJ; Goldhill DR; Yate PM; Flynn PJ
Br J Anaesth; 1990 Oct; 65(4):480-6. PubMed ID: 1979009
[TBL] [Abstract][Full Text] [Related]
27. The effects of hypercarbia and hypocarbia on pancuronium and vecuronium neuromuscular blockades in anesthetized humans.
Gencarelli PJ; Swen J; Koot HW; Miller RD
Anesthesiology; 1983 Nov; 59(5):376-80. PubMed ID: 6139044
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
Nathan N; Bonada G; Feiss P
Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
[TBL] [Abstract][Full Text] [Related]
29. Haemodynamic effects of high-dose vecuronium compared with pancuronium in beta-blocked patients with coronary artery disease during fentanyl-diazepam-nitrous oxide anaesthesia.
Husby P; Gramstad L; Rosland JH; Vamnes JS; Segadal L
Acta Anaesthesiol Scand; 1996 Jan; 40(1):26-31. PubMed ID: 8904256
[TBL] [Abstract][Full Text] [Related]
30. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
Noeldge G; Hinsken H; Buzello W
Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
[TBL] [Abstract][Full Text] [Related]
31. Rate of onset of good intubating conditions, respiratory depression and hand muscle paralysis after vecuronium.
Bencini A; Newton DE
Br J Anaesth; 1984 Sep; 56(9):959-65. PubMed ID: 6147155
[TBL] [Abstract][Full Text] [Related]
32. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
33. Atracurium and vecuronium: effect of dose on the time of onset.
Healy TE; Pugh ND; Kay B; Sivalingam T; Petts HV
Br J Anaesth; 1986 Jun; 58(6):620-4. PubMed ID: 2871849
[TBL] [Abstract][Full Text] [Related]
34. Dose-response studies with pancuronium, vecuronium and their combination.
Ferres CJ; Mirakhur RK; Pandit SK; Clarke RS; Gibson FM
Br J Clin Pharmacol; 1984 Dec; 18(6):947-50. PubMed ID: 6152177
[TBL] [Abstract][Full Text] [Related]
35. Neuromuscular effects of pipecuronium bromide.
Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
[TBL] [Abstract][Full Text] [Related]
36. Duration of vecuronium-induced neuromuscular block can be predicted by change of skin temperature over the thenar muscles.
Suzuki T; Kitajima O; Watanabe A; Nonaka H; Saeki S; Ogawa S
J Anesth; 2004; 18(3):172-6. PubMed ID: 15290414
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pharmacological actions of a bolus injection of suxamethonium: two phenomena of distinct duration.
d'Hollander AA; Agoston S; De Ville A; Cuvelier F
Br J Anaesth; 1983 Feb; 55(2):131-4. PubMed ID: 6131683
[TBL] [Abstract][Full Text] [Related]
38. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
Schwarz S; Agoston S; Houwertjes MC
Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
[TBL] [Abstract][Full Text] [Related]
39. Duration of exposure to sevoflurane affects dose-response relationship of vecuronium.
Suzuki T; Iwasaki K; Fukano N; Hariya S; Saeki S; Ogawa S
Br J Anaesth; 2000 Nov; 85(5):732-4. PubMed ID: 11094589
[TBL] [Abstract][Full Text] [Related]
40. Clinical studies on Org NC 45: comparison with pancuronium.
Kerr WJ; Baird WL
Br J Anaesth; 1982 Nov; 54(11):1159-65. PubMed ID: 6128012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
